Cargando…

XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial

BACKGROUND: Thin strut 3rd generation drug eluting stents offer the potential advantage over the previous generation of better technical performance and reduced neointimal proliferation parameters, which are linked to mid and late term device failure. AIM: To evaluate the performance of the Xlimus s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Testa, Luca, Pero, Gaetano, Bollati, Mario, Casenghi, Matteo, Popolo Rubbio, Antonio, Cuman, Magdalena, Moreno, Raul, Serra, Antoni, Gomez, Joan Antoni, Bedogni, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487315/ https://www.ncbi.nlm.nih.gov/pubmed/31061876 http://dx.doi.org/10.1016/j.ijcha.2019.100363

Ejemplares similares

A randomized control trial to assess optical coherence tomography parameters of the Xlimus drug-eluting stent: the XLIMIT trial
por: Testa, Luca, et al.
Publicado: (2023)

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
por: Testa, Luca, et al.
Publicado: (2019)

A patient‐specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique
por: De Marco, Federico, et al.
Publicado: (2021)

Bailout From Sinus Jailing: In-Series TAVR-in-TAVR to Avoid Coronary Flow Obstruction
por: Casenghi, Matteo, et al.
Publicado: (2021)

“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022)

Prokineticin-izing Doxorubicin-Damaged Hearts
por: Hirsch, Emilio
Publicado: (2019)

COVID-19: Lessons for an Urban(izing) World
por: Acuto, Michele
Publicado: (2020)

Hypertension- One ize does not fit all
por: Subashri, Mohanasundaram, et al.
Publicado: (2021)

Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized
por: Gammage, Payam A., et al.
Publicado: (2018)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial
por: Iñiguez, Andrés, et al.
Publicado: (2019)

Human(ized) monoclonal antibodies in atopic patients – state of the art
por: YALCIN, ARZU DIDEM, et al.
Publicado: (2020)

A RandomizEd trial of ENtERal Glutamine to minimIZE thermal injury (The RE-ENERGIZE Trial): a clinical trial protocol
por: Heyland, Daren K., et al.
Publicado: (2017)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Transcatheter Mitral Valve Repair with the PASCAL System after Early Edge-to-Edge Surgical Failure
por: Granata, Giuseppina, et al.
Publicado: (2021)

Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project
por: Testa, Luca, et al.
Publicado: (2023)

A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial
por: Abizaid, Alexandre, et al.
Publicado: (2023)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials
por: Alazzoni, Ashraf, et al.
Publicado: (2012)

Randomised trial of the comparison of drug-eluting stents in patients with diabetes: OCT DES trial
por: Hamshere, Stephen, et al.
Publicado: (2018)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial
por: Arroyo, Diego A, et al.
Publicado: (2018)

Estrogen-Eluting Stents
por: Ryu, Sung Kee, et al.
Publicado: (2009)

Cerebral Protection During Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta‐Analysis
por: Testa, Luca, et al.
Publicado: (2018)

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
por: Arroyo, Diego, et al.
Publicado: (2014)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials
por: Zhu, Ping, et al.
Publicado: (2018)

Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials
por: Testa, Luca, et al.
Publicado: (2017)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Gomez‐Lara, Josep, et al.
Publicado: (2021)

Antibiotic eluting sinus stents
por: Thompson, Harrison M., et al.
Publicado: (2020)

Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial
por: Chae, In-Ho, et al.
Publicado: (2017)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
por: Zbinden, Rainer, et al.
Publicado: (2016)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Stent Fracture after Everolimus-Eluting Stent Implantation
por: Almasood, Ali S., et al.
Publicado: (2011)

Early definite stent thrombosis with everolimus-eluting stents
por: Naito, Ryo, et al.
Publicado: (2015)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bucgkluag6d89oak1b23sil3a1